191 related articles for article (PubMed ID: 11682459)
1. Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin.
Jurasz P; Stewart MW; Radomski A; Khadour F; Duszyk M; Radomski MW
Br J Pharmacol; 2001 Nov; 134(5):1104-12. PubMed ID: 11682459
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characteristics of solid-phase von Willebrand factor in human platelets.
Radomski A; Stewart MW; Jurasz P; Radomski MW
Br J Pharmacol; 2001 Nov; 134(5):1013-20. PubMed ID: 11682449
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
4. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.
Roberts W; Michno A; Aburima A; Naseem KM
J Thromb Haemost; 2009 Dec; 7(12):2106-15. PubMed ID: 19765213
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
7. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
[TBL] [Abstract][Full Text] [Related]
8. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
9. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Bazou D; Santos-Martinez MJ; Medina C; Radomski MW
Br J Pharmacol; 2011 Apr; 162(7):1577-89. PubMed ID: 21182493
[TBL] [Abstract][Full Text] [Related]
11. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione.
Langford EJ; Parfitt A; de Belder AJ; Marrinan MT; Martin JF
Thromb Haemost; 1997 Dec; 78(6):1516-9. PubMed ID: 9423805
[TBL] [Abstract][Full Text] [Related]
12. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
13. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
[TBL] [Abstract][Full Text] [Related]
14. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
O'Brien JR; Etherington MD
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
16. Shear stress-induced binding of von Willebrand factor to platelets.
Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
[TBL] [Abstract][Full Text] [Related]
17. Differential response of human and bovine platelets to bovine von Willebrand factor and vascular subendothelium.
Rao GH; Escolar G; White JR; Weiss DJ; Burris S; Ordinas A; White JG
Platelets; 2001 May; 12(3):150-5. PubMed ID: 11304416
[TBL] [Abstract][Full Text] [Related]
18. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
20. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
